UPDATE - Nomura Securities Initiates Coverage on Cisco (CSCO) with a Buy; 12% FY12-14 EPS Growth on Gross Margin Turnaround
Tweet
Share
E-mailGet Alerts CSCO Hot Sheet
Price: $111.46 +1.71%
Rating Summary:
35 Buy, 27 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
35 Buy, 27 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Nomura Securities initiates coverage on Cisco (NASDAQ: CSCO) with a Buy. PT $24.00.
Analyst, Stuart Jeffrey, said, "Our analysis suggests that consensus estimates have understated the potential for revenue growth and the likelihood of gross margin improvement. We see scope for market estimates to move higher during the course of the next three quarters (fiscal 2012) and to accelerate thereafter, driven by 1) gross margin recovery post Q2 due to a healthier product mix and 2) revenue upside on solid routing and switching end-market trends and solid execution in higher-gross-margin divisions. Our adjusted FY12 and FY13 EPS ests are $2.09 and $2.33, respectively."
"Risks include the possibility of major data center contract wins by Juniper (Nasdaq: JNPR) and HP (NYSE: HPQ) in H1 2012. However, we currently consider this unlikely."
To see more ratings on CSCO, Click Here
Analyst, Stuart Jeffrey, said, "Our analysis suggests that consensus estimates have understated the potential for revenue growth and the likelihood of gross margin improvement. We see scope for market estimates to move higher during the course of the next three quarters (fiscal 2012) and to accelerate thereafter, driven by 1) gross margin recovery post Q2 due to a healthier product mix and 2) revenue upside on solid routing and switching end-market trends and solid execution in higher-gross-margin divisions. Our adjusted FY12 and FY13 EPS ests are $2.09 and $2.33, respectively."
"Risks include the possibility of major data center contract wins by Juniper (Nasdaq: JNPR) and HP (NYSE: HPQ) in H1 2012. However, we currently consider this unlikely."
To see more ratings on CSCO, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
- Baird Starts Eaton Corporation (ETN) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
